Rosenblum Mark J
Insider CIK 1329154 · ADXS Chief Financial Officer · DCOY Exec VP Finance, CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DCOY Decoy Therapeutics Inc. | A Award | 2026-08-31 | 2026-09-02 | 9,682 | — | $0 | 11,363 | SEC↗ |
| DCOY Decoy Therapeutics Inc. | A Award | 2026-08-31 | 2026-09-02 | 9,682 | — | $0 | 11,363 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2025-11-20 | 2025-11-20 | 20,000 | $0.80 | $16.0K | 20,177 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2024-02-20 | 2024-02-22 | 22,500 | — | $0 | 22,500 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2023-02-13 | 2023-02-15 | 6,432 | — | $0 | 21,851 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2023-01-03 | 2023-01-05 | 8,000 | — | $0 | 15,419 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2022-11-03 | 2022-11-07 | 7,314 | $1.73 | $12.7K | 155,633 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2022-11-03 | 2022-11-08 | 7,314 | $1.73 | $12.7K | 13,245 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2022-11-03 | 2022-12-12 | 1,488 | $1.73 | $2.6K | 7,419 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-05-31 | 2022-05-31 | 28,000 | $0.18 | $5.0K | 148,319 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2022-05-03 | 2022-05-05 | 10,000 | $0.19 | $1.9K | 120,319 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-03-03 | 2022-03-09 | 76,246 | $0.39 | $29.7K | 110,319 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2022-01-20 | 2022-01-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2021-11-03 | 2021-11-05 | 7,787 | $0.72 | $5.6K | 34,073 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2021-05-03 | 2021-05-05 | 9,563 | $0.57 | $5.5K | 26,286 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-12-02 | 2020-12-04 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2020-11-03 | 2020-11-05 | 4,723 | $0.56 | $2.6K | 16,723 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-08-17 | 2020-08-18 | 5,000 | $1.00 | $5.0K | 12,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-07-14 | 2020-07-16 | 49,955 | — | $0 | 49,955 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-03-23 | 2020-03-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-02-19 | 2020-02-20 | 2,000 | $0.95 | $1.9K | 7,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-02-13 | 2020-02-13 | 5,000 | $0.86 | $4.3K | 5,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-01-31 | 2014-02-04 | 530 | — | $0 | 113,822 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2014-01-31 | 2014-02-04 | 48 | $4.49 | $216 | 113,774 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2014-01-07 | 2014-01-09 | 1,565 | $4.03 | $6.3K | 21,616 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-01-07 | 2014-01-09 | 2,985 | — | $0 | 23,181 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-01-07 | 2014-01-09 | 20,000 | — | $0 | 41,616 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-01-07 | 2014-01-09 | 80,000 | — | $0 | 121,616 | SEC↗ |
| ADXS Advaxis, Inc. | F Tax w/h | 2014-01-07 | 2014-01-09 | 8,324 | $4.03 | $33.5K | 113,292 | SEC↗ |
| ADXS Advaxis, Inc. | P Buy deriv | 2013-10-24 | 2013-10-28 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ADXS Advaxis, Inc. | P Buy | 2013-10-24 | 2013-10-28 | 12,000 | $4.00 | $48.0K | 20,196 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2013-03-14 | 2013-07-10 | 2,400,000 | — | $0 | 2,400,000 | SEC↗ |
| ADXS Advaxis, Inc. | D To issuer deriv | 2012-05-14 | 2012-05-16 | 0 | — | $0 | 0 | SEC↗ |
| ADXS Advaxis, Inc. | D To issuer deriv | 2012-05-14 | 2012-05-16 | 196,078 | — | $0 | 0 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2012-05-14 | 2012-05-16 | 686,275 | — | $0 | 686,275 | SEC↗ |